Health Care & Life Sciences » Pharmaceuticals | Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc.
Stock Exchange Other OTC
EPS
$0.78
Market Cap
$22.09 M
Shares Outstanding
22.08 M
Public Float
8.08 M

Profile

Address
11 Commerce Drive
Cranford New Jersey 07016
United States
Employees -
Website http://www.citiuspharma.com
Updated 07/08/2019
Citius Pharmaceuticals, Inc. engages in the development and commercialization of therapeutic products. Its products include Mino-Lok and hydrocortisone-lidocaine. The company was founded on September 09, 2010 and is headquartered in Cranford, NJ.

Financials

View All

Leonard L. Mazur
Executive Chairman & Secretary
Myron Z. Holubiak
President, Chief Executive Officer & Director